Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer
Cancer-related fatigue (CRF) is a common symptom in breast cancer patients and survivors, which can substantially impair quality of life. Previous studies suggested that CRF may be associated with poorer survival outcomes, but had limited follow-up duration or insufficient adjustment for established...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 May 2025
|
| In: |
Breast cancer research
Year: 2025, Volume: 27, Pages: 1-9 |
| ISSN: | 1465-542X |
| DOI: | 10.1186/s13058-025-02036-3 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13058-025-02036-3
|
| Author Notes: | Philipp Heumann, Axel Benner, Sabine Behrens, Jenny Chang-Claude & Petra Seibold |
| Summary: | Cancer-related fatigue (CRF) is a common symptom in breast cancer patients and survivors, which can substantially impair quality of life. Previous studies suggested that CRF may be associated with poorer survival outcomes, but had limited follow-up duration or insufficient adjustment for established prognostic factors. The aim of this analysis was to assess the prognostic value of CRF at the end of radiotherapy for overall survival in a cohort of women with breast cancer with a median follow-up time of 19 years. |
|---|---|
| Item Description: | Gesehen am 29.09.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1465-542X |
| DOI: | 10.1186/s13058-025-02036-3 |